{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:01:08Z","timestamp":1762506068262,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA134964"],"award-info":[{"award-number":["R01CA134964"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ygyno.2013.03.006","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T13:15:46Z","timestamp":1363180546000},"page":"43-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer"],"prefix":"10.1016","volume":"130","author":[{"given":"Jason D.","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth T.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cande V.","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred I.","family":"Neugut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharyn N.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Siddiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2013.03.006_bb0005","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"9213","key":"10.1016\/j.ygyno.2013.03.006_bb0010","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"9658","key":"10.1016\/j.ygyno.2013.03.006_bb0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2013.03.006_bb0020","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","article-title":"A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study","volume":"112","author":"Homesley","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.03.006_bb0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2007.06.014","article-title":"The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer","volume":"107","author":"Alvarez Secord","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.03.006_bb0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ygyno.2013.03.006_bb0035","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0360-3016(01)01765-5","article-title":"The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial","volume":"51","author":"Creutzberg","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ygyno.2013.03.006_bb0040","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.ijrobp.2012.02.044","article-title":"A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418","volume":"84","author":"Jhingran","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ygyno.2013.03.006_bb0045","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0360-3016(03)00325-0","article-title":"Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy","volume":"56","author":"Mundt","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ygyno.2013.03.006_bb0050","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijrobp.2011.02.007","article-title":"Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis","volume":"81","author":"Sher","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ygyno.2013.03.006_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2003.05.001","article-title":"A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy","volume":"69","author":"Roeske","year":"2003","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.03.006_bb0060","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0360-3016(02)03801-4","article-title":"Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies","volume":"54","author":"Brixey","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ygyno.2013.03.006_bb0065","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","article-title":"Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies","volume":"52","author":"Mundt","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"10.1016\/j.ygyno.2013.03.006_bb0070","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.2012.460","article-title":"Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer","volume":"307","author":"Sheets","year":"2012","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ygyno.2013.03.006_bb0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jnci\/djr100","article-title":"Adoption of intensity-modulated radiation therapy for breast cancer in the United States","volume":"103","author":"Smith","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"10.1016\/j.ygyno.2013.03.006_bb0080","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.ygyno.2013.03.006_bb0085","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2013.03.006_bb0090","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ygyno.2013.03.006_bb0095","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ijrobp.2004.12.029","article-title":"Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size","volume":"62","author":"Ahamad","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ygyno.2013.03.006_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(01)01664-9","article-title":"Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation","volume":"51","author":"Portelance","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ygyno.2013.03.006_bb0105","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ijrobp.2004.06.253","article-title":"Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies","volume":"61","author":"Wong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ygyno.2013.03.006_bb0110","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0360-3016(03)00521-2","article-title":"Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy","volume":"57","author":"Lujan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ygyno.2013.03.006_bb0115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijrobp.2012.04.044","article-title":"Prospective study of functional bone marrow-sparing intensity modulated radiation theraphy with concurrent chemotheraphy for pelvic malignancies","volume":"85","author":"Liang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ygyno.2013.03.006_bb0120","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00005650-199308000-00006","article-title":"Potential for cancer related health services research using a linked Medicare-tumor registry database","volume":"31","author":"Potosky","year":"1993","journal-title":"Med Care"},{"issue":"7","key":"10.1016\/j.ygyno.2013.03.006_bb0125","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005650-200007000-00004","article-title":"Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer","volume":"38","author":"Du","year":"2000","journal-title":"Med Care"},{"issue":"8 Suppl.","key":"10.1016\/j.ygyno.2013.03.006_bb0130","first-page":"IV-3","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"issue":"23","key":"10.1016\/j.ygyno.2013.03.006_bb0135","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/djp387","article-title":"Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer","volume":"101","author":"Hershman","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ygyno.2013.03.006_bb0140","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/cncr.22826","article-title":"Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer","volume":"110","author":"Du","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2013.03.006_bb0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0021-9681(86)90111-6","article-title":"Assessing illness severity: does clinical judgment work?","volume":"39","author":"Charlson","year":"1986","journal-title":"J Chronic Dis"},{"issue":"12","key":"10.1016\/j.ygyno.2013.03.006_bb0150","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.03.006_bb0155","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1200\/JOP.2011.000484","article-title":"Use and benefits of laparoscopic hysterectomy for stage I endometrial cancer among Medicare beneficiaries","volume":"8","author":"Wright","year":"2012","journal-title":"J Oncol Pract"},{"issue":"6","key":"10.1016\/j.ygyno.2013.03.006_bb0160","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/cncr.24160","article-title":"Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time","volume":"115","author":"Wright","year":"2009","journal-title":"Cancer"},{"issue":"8 Suppl.","key":"10.1016\/j.ygyno.2013.03.006_bb0165","first-page":"IV-104","article-title":"Estimating health care costs related to cancer treatment from SEER-Medicare data","volume":"40","author":"Brown","year":"2002","journal-title":"Med Care"},{"issue":"12","key":"10.1016\/j.ygyno.2013.03.006_bb0170","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jnci\/djn175","article-title":"Evaluation of trends in the cost of initial cancer treatment","volume":"100","author":"Warren","year":"2008","journal-title":"J Natl Cancer Inst"},{"year":"2012","series-title":"Logistic regression using SAS: theory and application","author":"Allison","key":"10.1016\/j.ygyno.2013.03.006_bb0175"},{"year":"2005","series-title":"Quantile regression","author":"Koenker","key":"10.1016\/j.ygyno.2013.03.006_bb0180"},{"issue":"14","key":"10.1016\/j.ygyno.2013.03.006_bb0185","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1002\/cncr.25205","article-title":"Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort","volume":"116","author":"Guadagnolo","year":"2010","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813001546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813001546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:33:43Z","timestamp":1758771223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813001546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0090825813001546"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.03.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}